Ezcurra D

No ORCID on file · 4 papers in corpus
2012
Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-10-9

Variability in the subfertile patient population excludes the possibility of a single approach to controlled ovarian stimulation (COS) covering all the requirements of a patient. Modern technology has led to the development of new drugs, tr…

other 2011
Contemporary genetic technologies and female reproduction
Human Reproduction Update ·doi:10.1093/humupd/dmr033

BACKGROUND: The Fifth Evian Annual Reproduction (EVAR) Workshop Meeting discussed knowledge regarding contemporary genetics in female reproduction. METHODS: Specialist reproductive medicine clinicians and geneticists delivered presentation…

2011
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-9-82

BackgroundIn the last two decades, pregnancy rates for patients undergoing in-vitro fertilisation (IVF) have significantly increased. Some of the major advances responsible for this improvement were the introduction of controlled ovarian st…

2010
Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-8-112

BackgroundHuman menopausal gonadotrophins and recombinant human follicle stimulating hormone are the two main gonadotrophin products utilized for controlled ovarian stimulation in assisted reproductive technologies. In this meta-analysis, t…